Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy

Journal of Clinical Investigation

Volumn 108, Issue 6, 2001, Pages 895-904

  Wells, A D ^a   Walsh, M C ^a   Bluestone, J A ^a   Turka, L A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CLONAL ANERGY; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0034823168     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI13220     Document Type: Article

References (51)

1. Heterogeneity of single cell cytokine gene expression in clonal T cell populations
2. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response
3. Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: Effector function is linked to proliferative capacity
4. T cell effector function and anergy avoidance are quantitatively linked to cell division
5. CD28/B7 system of T cell costimulation
6. CTLA-4 and T cell activation
7. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression
8. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones
9. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation
10. CTLA-4 ligation blocks CD28-dependent T cell activation
11. CTLA-4 Engagement inhibits IL2 accumulation and cell cycle progression upon activation of resting T cells
12. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement
13. CTLA-4-Mediated inhibition of early events of T cell proliferation
14. CTLA-4 regulates induction of anergy in vivo
15. A cell culture model for T lymphocyte clonal anergy
16. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation
17. Individual T cells hold unexpected clues to the nature of anergy and memory
18. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation
19. Evidence for repression of IL-2 gene activation in anergic T cells
20. Dealing from the evolutionary pawnshop: How lymphocytes make decisions
21. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations
22. Helper T cell differentiation is controlled by the cell cycle
23. Cell division regulates the T cell cytokine repertoire, revealing a mechanism underlying immune class regulation
24. Cancer cell cycles
25. Principles of CDK regulation
26. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin
27. Reversal of in vitro T cell clonal anergy by IL-2 stimulation
28. p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes
29. Th1 cell anergy and blockade in G-a phase of the cell cycle
30. Is CTLA-4 a master switch for peripheral T cell rolerance?
31. CTLA-interaction is sufficient to costimulate T cell clonal expansion
32. Paradoxical inhibition of T-cell function in response to CTLA-4 blockade; heterogeneity within the human T-cell population
33. Receptor-stimulated death pathway is opened by antigen in mature T cells
34. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis
35. Antigen-experienced T cells undergo a transient phase of unresponsiveness following optimal stimulation
36. Induction of T cell anergy in the absence of CTLA-4/B7 interaction
37. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells
38. Direct evidence that functionally impaired CD4+ T cells persist in vivo following induction of peripheral tolerance
39. In vivo CD4+ T cell tolerance induction versus priming is independent of the rate and number of cell divisions
40. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4
41. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
42. CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis
43. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance
44. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo
45. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
46. Blockade of CD28/B7-interaction prevents epitope spreading and clinical relapses of murine EAE
47. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis
48. In vivo responses of CD4+ and CD8+ cells to bacterial superantigens
49. In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B
50. Proliferation is a pre-requisite for bacterial superantigen-induced T cell apoptosis in vivo
51. CTLA-4 regulates tolerance induction and T cell differentiation in vivo